Company: XTIA
Filing Date: 2025-04-18
Form Type: POS AM
Source: 0001213900-25-033058
Chunk: 51

Company: XTI Aerospace, Inc.
Filing Date: 2025-04-18
Form: POS AM
Chunk 51
---
5 million. Maxim Group LLC (“Maxim”) served as the Company’s exclusive placement agent in                      
 connection with the offering of the May 2023 Warrants pursuant to the terms of a placement agency agreement, dated May 15, 2023, by and    
 between the Company and Maxim. Pursuant to the terms of the placement agency agreement, the Company agreed to pay Maxim (i) a cash fee     
 equal to 2.75% of the gross proceeds received by the Company from the sale of the May 2023 Warrants, due at closing, and (ii) a cash fee   
 equal to 5.5% of the gross proceeds received by the Company upon the exercise of May 2023 Warrants for cash, to be paid on a weekly basis  
 during the exercise period of the May 2023 Warrants. The Company also agreed to reimburse Maxim up to $50,000 for expenses incurred in     
 connection with the offering. The aggregate net proceeds from the offering of the May 2023 Warrants, after deducting placement agent fees  
 and other offering expenses payable by the Company, were approximately $1.4 million.                                                       |

| 10. | On December 15, 2023, the Company entered into inducement letter agreements                                                                     
 (the “Inducement Agreements”) with certain holders (the “Holders”) of the May 2023 Warrants (the “Existing                                      
 Warrants”), pursuant to which the Holders exercised an aggregate of 1,965 Existing Warrants for cash at the New Exercise Price (as              
 defined below) and the Company (i) reduced the per share exercise price of the Existing Warrants from $$2,500 to $1,282.50 per share (the       
 “New Exercise Price”), which is equal to a 30% discount to the average closing price of the Company’s Common Stock (as                          
 reflected on Nasdaq.com) for the five trading days prior to the execution of the Inducement Agreements, and (ii) issued the Holders warrants    
 (the “New Warrants”) to purchase up to an aggregate of 1,965 shares of Common Stock (each Holder received a New Warrant to                      
 purchase 100% of the number of shares of Common Stock issued to such Holder upon exercise of such Holder’s Existing Warrants), exercisable      
 five years from their issuance date with an initial exercise price per share of $1,831, which was subsequently reduced by the Company           
 to $